未登录

G

Goran Stevanović

University of Belgrade

H指数:18

被引数:895

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Extreme procalcitonin elevation without infection in a patient with lung adenocarcinoma undergoing transformation to small-cell lung carcinoma: a case report

极高水平降钙素原无感染性升高：1例肺腺癌向小细胞肺癌转化患者的病例报告

IF2.5

2026-05-010

PRE

Beyond Binary Positivity: Spectrum of Nodal Tumor Burden in Sentinel Lymph Node Biopsy for High-Risk Cutaneous Squamous Cell Carcinoma

超越二元阳性：高风险皮肤鳞状细胞癌哨兵淋巴结活检中淋巴结肿瘤负荷谱

Dermatopathology

IF1.7

2026-04-300

OA

Evaluating Tuberculosis and Drug Resistance in Serbia: A Ten-Year Experience from a Tertiary Center

ANTIBIOTICS-BASEL

IF4.6

2025-03-180

OA

Dermatophytes: Update on Clinical Epidemiology and Treatment

皮肤癣菌：临床流行病学与治疗进展

IF2.9

2024-11-213

PRE

Incremental costs of hospital-acquired infections in COVID-19 patients in an adult intensive care unit of a tertiary hospital from a low-resource setting

ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL

IF4.4

2023-04-211

OAAI

Predictors of Vancomycin-Resistant Enterococcus spp. Intestinal Carriage among High-Risk Patients in University Hospitals in Serbia

ANTIBIOTICS-BASEL

IF4.6

2022-09-094

OA

Antibiotic (Mis)Use in COVID-19 Patients before and after Admission to a Tertiary Hospital in Serbia

ANTIBIOTICS-BASEL

IF4.6

2022-06-2414

OA

Antioxidant Genetic Profile Modifies Probability of Developing Neurological Sequelae in Long-COVID

IF6.6

2022-05-1212

OAAI

SOD2 rs4880 and GPX1 rs1050450 polymorphisms do not confer risk of COVID-19, but influence inflammation or coagulation parameters in Serbian cohort

IF7.4

2022-03-3112

OAAI

GSTO1, GSTO2 and ACE2 Polymorphisms Modify Susceptibility to Developing COVID-19

JOURNAL OF PERSONALIZED MEDICINE

IF3

2022-03-1417

OAAI

Antimicrobial Use in Hospitalised Patients with COVID-19: An International Multicentre Point-Prevalence Study

ANTIBIOTICS-BASEL

IF4.6

2022-01-289

OA

Emerging Clinical Features of COVID-19 Related Pancreatitis: Case Reports and Review of the Literature

FRONTIERS IN MEDICINE

IF3

2022-01-186

OAAI

Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study

MICROBIOLOGY SPECTRUM

IF3.8

2021-12-2211

OAAI

Perez-Recio, Sandra; Pallares, Natalia; Grijota-Camino, Maria D.; Sanchez-Montalva, Adrian; Barcia, Laura; Campos-Gutierrez, Silvia; Pomar, Virginia; Rabunal-Rey, Ramon; Balcells, Maria Elvira; Gazel, Deniz; Montiel, Natalia; Vicente, Diego; Goic-Barisic, Ivana; Schon, Thomas; Paues, Jakob; Marekovic, Ivana; Cacho-Calvo, Juana; Barac, Aleksandra; Goletti, Delia; Garcia-Gasalla, Mercedes; Maria Barcala, Jose; Teresa Tortola, Maria; Anibarro, Luis; Suarez-Toste, Isabel; Moga, Esther; Gude-Gonzalez, Maria J.; Naves, Rodrigo; Karsligil, Tekin; Martin-Penaranda, Tania; Stevanovic, Goran; Trigo, Matilde; Rubio, Veronica; Karaoglan, Ilkay; Bayram, Nazan; Alcaide, Fernando; Tebe, Cristian; Santin, Miguel

GSTP1 and GSTM3 Variant Alleles Affect Susceptibility and Severity of COVID-19

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2021-12-2014

OAAI

The Impact of COVID-19 on the Profile of Hospital-Acquired Infections in Adult Intensive Care Units

ANTIBIOTICS-BASEL

IF4.6

2021-09-2333

OA

Association of Vitamin D, Zinc and Selenium Related Genetic Variants With COVID-19 Disease Severity

FRONTIERS IN NUTRITION

IF5.1

2021-06-0427

OAAI

Hospital-acquired infections in the adult intensive care unit-Epidemiology, antimicrobial resistance patterns, and risk factors for acquisition and mortality

AMERICAN JOURNAL OF INFECTION CONTROL

IF2.4

2020-10-0178

OAAI

Allergic diseases of upper and lower airways caused by fungi: one or two diseases?

EUROPEAN RESPIRATORY JOURNAL

IF21

2018-11-190

PRE

The sequence analysis of Epstein-Barr virus EBNA1 gene: could viral screening markers for nasopharyngeal carcinoma be identified?

MEDICAL MICROBIOLOGY AND IMMUNOLOGY

IF3

2018-09-105

PREAI

Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults

季节性三价灭活流感裂解疫苗的安全性和免疫原性: 一项针对健康塞尔维亚成年人的I期随机临床试验

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2018-02-233

OAAI